Kawaguchi, K., Han, Q., Li, S., Tan, Y., Igarashi, K., Kiyuna, T., . . . Hoffman, R. M. (2018). Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: Implications for chronic clinical cancer therapy and prevention. Cell Cycle.
Style de citation ChicagoKawaguchi, Kei, et al. "Targeting Methionine With Oral Recombinant Methioninase (o-rMETase) Arrests a Patient-derived Orthotopic Xenograft (PDOX) Model of BRAF-V600E Mutant Melanoma: Implications for Chronic Clinical Cancer Therapy and Prevention." Cell Cycle 2018.
Style de citation MLAKawaguchi, Kei, et al. "Targeting Methionine With Oral Recombinant Methioninase (o-rMETase) Arrests a Patient-derived Orthotopic Xenograft (PDOX) Model of BRAF-V600E Mutant Melanoma: Implications for Chronic Clinical Cancer Therapy and Prevention." Cell Cycle 2018.